# Correction to: Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study

PMC · DOI: 10.1093/jbmr/zjaf031 · Journal of Bone and Mineral Research · 2025-03-03

## Full-text entities

- **Diseases:** osteogenesis imperfecta (MESH:D010013)
- **Chemicals:** Setrusumab (MESH:C000622723)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12010154/full.md

---
Source: https://tomesphere.com/paper/PMC12010154